Related Experiment Video
Updated: Feb 9, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Atopic Dermatitis: Early Treatment in Children
Amy Huang1, Christine Cho2, Donald Y M Leung2
1Department of Dermatology, State University of New York Downstate Medical Center, Brooklyn, NY.
Insights
Early treatment of childhood atopic dermatitis (AD) is crucial for managing skin inflammation and preventing allergic diseases. A stepwise approach using moisturizers and anti-inflammatory agents, tailored to severity, is recommended for effective AD management.
Area of Science:
- Dermatology
- Allergology
- Pediatrics
Background:
- Atopic dermatitis (AD) management traditionally focuses on reducing skin inflammation and barrier repair.
- Current AD treatment guidelines emphasize a stepwise approach, starting with emollients and progressing to anti-inflammatory therapies based on disease severity.
- A defective skin barrier in AD allows allergen entry, potentially initiating the 'atopic march' towards other allergic conditions.
Purpose of the Study:
- To review current treatment options and strategies for pediatric atopic dermatitis.
- To emphasize the importance of early intervention in managing AD and preventing the development of other atopic diseases.
- To discuss the efficacy and safety of various interventions for pediatric AD.
Main Methods:
- Review of existing literature on pediatric atopic dermatitis treatments.
- Analysis of therapeutic regimens including topical moisturizers, anti-inflammatory medications, and allergen avoidance.
- Discussion of severity-based, stepwise treatment approaches.
Main Results:
- Essential pediatric AD treatments include moisturizers, topical anti-inflammatories, allergen avoidance, and infection management.
- Systemic therapies are reserved for severe cases resistant to topical treatments due to potential toxicities.
- Early AD treatment may prevent the development of food allergy, asthma, and allergic rhinitis.
Conclusions:
- A severity-based, stepwise therapeutic strategy is essential for effective pediatric AD management.
- Early and comprehensive treatment of AD is critical not only for skin health but also for mitigating the risk of developing other atopic conditions.
- Further evidence on the efficacy and safety of interventions supports tailored treatment plans for pediatric AD.
Abstract:
Therapeutic regimens for the treatment and long-term management of AD traditionally had a two-fold objective of decreasing skin inflammation and repairing the defective skin barrier. Essential treatments for AD in children should include topical moisturizers for skin hydration and prevention of flares, topical anti-inflammatory medications (e.g. corticosteroids, calcineurin inhibitors, PDE4 inhibitor), allergen/irritant avoidance, and treatment of skin infections. Treatment regimens should be severity-based, and implemented in a stepwise approach tailored to the individual patient. This stepwise approach includes initial use of emollients, gentle skin care, and escalating to more potent anti-inflammatory treatments as the disease severity increases. Currently available systemic medications should be reserved for the presence of recalcitrance to topical therapies due to associated toxicities. We believe that early treatment of AD is not only essential in treating the skin disease, but also in preventing the development of additional atopic diseases, such as food allergy, asthma and allergic rhinitis. The defective skin barrier of AD permits a route of entry for food and environmental allergens, and upon exposure, keratinocytes secrete TSLP, which activates the TH2 pathway. This TH2 differentiation sets off the atopic march and the subsequent diseases that are seen. This review highlights treatment options and strategies in pediatric AD therapy with an emphasis on early therapy. Supporting evidence on the efficacy and safety of each intervention will be discussed.
More Related Videos
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Related Concept Videos
Drug Dosing: Infants and Children
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...